Assyro AI

Orange Book product · Brand (NDA)

SUBSYS

FENTANYL

Brand (NDA)NDA 202788DISCN BTCP PHARMA

At a glance

Jan 04, 2012

Approved

Brand (NDA)

Application

Not listed

TE code

10

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Jan 04, 2012

    14 yr 8 mo ago

  2. Today

  3. Patent 10016403 expires

    Listed drug product patent expiration.

    Jan 25, 2027

    in 7 mo

  4. Patent 10610523 expires

    Listed drug product patent expiration.

    Jan 25, 2027

    in 7 mo

  5. Patent 8835459 expires

    Listed drug product patent expiration.

    Jan 25, 2027

    in 7 mo

  6. Patent 8835460 expires

    Listed drug product patent expiration.

    Jan 25, 2027

    in 7 mo

  7. Patent 9241935 expires

    Listed drug product patent expiration.

    Jan 25, 2027

    in 7 mo

  8. Patent 9289387 expires

    Listed drug product patent expiration.

    Jan 25, 2027

    in 7 mo

  9. Patent 9642797 expires

    Listed drug product patent expiration.

    Jan 25, 2027

    in 7 mo

  10. Patent 9642844 expires

    Listed drug product patent expiration.

    Jan 25, 2027

    in 7 mo

  11. Patent 8486972 expires

    Listed drug product patent expiration.

    Apr 27, 2030

    in 3 yr 11 mo

  12. Patent 8486973 expires

    Listed method-of-use patent (U-55) expiration.

    Apr 27, 2030

    in 3 yr 11 mo

Pharmaceutical detail

Active ingredient

FENTANYL

Strength

0.1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Dosage form

SPRAY

Route

SUBLINGUAL

TE code

Not listed

Application

NDA 202788

Product number

001

Marketing status

DISCN

Reference listed drug (RLD)

Yes

Reference standard (RS)

No

Active-ingredient family

View full family

This is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.

Listed patents (10)

Patents listed in the FDA Orange Book for this product, with expiration date and patent type.
PatentExpiresInType
10016403Jan 25, 2027in 7 mo
Product
10610523Jan 25, 2027in 7 mo
Product
8835459Jan 25, 2027in 7 mo
Product
8835460Jan 25, 2027in 7 mo
ProductU-55
9241935Jan 25, 2027in 7 mo
Product
9289387Jan 25, 2027in 7 mo
ProductU-55
9642797Jan 25, 2027in 7 mo
ProductU-55
9642844Jan 25, 2027in 7 mo
Product
8486972Apr 27, 2030in 3 yr 11 mo
Product
8486973Apr 27, 2030in 3 yr 11 mo
U-55
Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.